603367.SHG Cisen Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
13.39 CNY
Close of Nov 4, 2026
12.13 21.99
Market cap
CNY 6.06B
P/E
15.4x
P/B
0.93x
ROE
7.3%
Dividend yield
3.02%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603367.SHG undervalued?

Graham number
Price13.39
Graham value16.77
Discount20.2%

603367.SHG trades 20.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cisen Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Cisen Pharmaceutical Co Ltd yet.

Cisen Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cisen Pharmaceutical Co Ltd

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, anesthetic and analgesic drugs, obstetrics and gynecology medication, digestive system medicatio…

Full company profile